Status:
COMPLETED
Dexamethasone for Post Traumatic Headache
Lead Sponsor:
Montefiore Medical Center
Conditions:
Post-Traumatic Headache
Eligibility:
All Genders
16+ years
Phase:
PHASE4
Brief Summary
This is a randomized study of intravenous metoclopramide + intravenous dexamethasone versus intravenous metoclopramide for patients with acute post-traumatic headache.
Eligibility Criteria
Inclusion
- Meet International Classification of Headache Disorders criteria for acute post-traumatic headache as follows:
- Traumatic injury to the head has occurred
- Headache has developed within 7 days of injury to the head
- Headache is not better accounted for by another diagnosis (e.g., migraine or tension-type headache)
- The headache must be rated as moderate or severe in intensity at the time of initial evaluation
Exclusion
- More than ten days have elapsed since the head trauma
- Headache has already been treated with an anti-dopaminergic medication
- Medication allergies
- Contra-indications including pheochromocytoma, seizure disorder, Parkinson's disease, use of MAO inhibitors, and use of anti-rejection transplant medications
Key Trial Info
Start Date :
February 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2024
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT04799015
Start Date
February 24 2021
End Date
December 22 2024
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore
The Bronx, New York, United States, 10467